SCHEMBL5899463

SCHEMBL5899463

CC(C)(NS(=O)(=O)c1ccc(Br)cc1)C(=O)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ITGA1 P56199 1/20 0.49
MMP2 P08253 7/20 0.45
MMP1 P03956 6/20 0.45
MMP9 P14780 6/20 0.45
MMP13 P45452 6/20 0.45
BLM P54132 1/20 0.45
CA1 P00915 1/20 0.45
CA2 P00918 1/20 0.45
MMP8 P22894 1/20 0.45
PTGS2 P35354 2/20 0.44
PTGS1 P23219 1/20 0.44
KAT6A Q92794 1/20 0.44
MMP3 P08254 4/20 0.43
MMP7 P09237 4/20 0.43
IDO1 P14902 2/20 0.43
EGFR P00533 1/20 0.43
ERBB2 P04626 1/20 0.43
ALDH1A1 P00352 1/20 0.42
MMP14 P50281 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5899488 0.89 KAT6A (0.49) MMP2MMP1MMP9MMP13CA1
SCHEMBL5899419 0.87 ALDH1A1 (0.49) MMP2MMP1MMP9MMP13CA1
SCHEMBL5899417 0.87 ADAMTS4 (0.50) MMP2MMP1MMP9MMP13MMP8
SCHEMBL5899422 0.85 FLT1 (0.57) MMP2MMP1MMP9MMP13CA1
SCHEMBL5899495 0.85 ALDH1A1 (0.50) CA1CA2ALDH1A1
SCHEMBL5899456 0.83 MMP2 (0.59) MMP2MMP1MMP9MMP13KAT6A
SCHEMBL14676363 0.83 MMP2 (0.52) MMP2MMP1MMP9MMP13CA1
SCHEMBL5899452 0.81 KAT6A (0.48) CA2KAT6AALDH1A1
SCHEMBL5899486 0.80 KAT6A (0.57) KAT6AALDH1A1
SCHEMBL5899671 0.79 ACLY (0.44) KAT6AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060025445-A1 11-Beta HSD1 inhibitors WYETH 2006-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025445-A1 11-Beta HSD1 inhibitors HSD11B1, HSD11B2, HSD3B1 ITGA1 3934/4885MMP2 1212/4885MMP1 369/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.